BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26116334)

  • 1. Carbapenem-resistant Enterobacteriaceae carriers in acute care hospitals and postacute-care facilities: The effect of organizational culture on staff attitudes, knowledge, practices, and infection acquisition rates.
    Fedorowsky R; Peles-Bortz A; Masarwa S; Liberman D; Rubinovitch B; Lipkin V
    Am J Infect Control; 2015 Sep; 43(9):935-9. PubMed ID: 26116334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Distribution of Educational Materials for Carbapenem-Resistant Enterobacteriaceae Among Acute and Long-term Care Facilities.
    Kram JJ; Borlaug G; Safdar N; Sethi A
    WMJ; 2015 Apr; 114(2):48-51. PubMed ID: 26756056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.
    Schwaber MJ; Carmeli Y
    Clin Infect Dis; 2014 Mar; 58(5):697-703. PubMed ID: 24304707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Success of a National Intervention in Controlling Carbapenem-resistant Enterobacteriaceae in Israel's Long-term Care Facilities.
    Ben-David D; Masarwa S; Fallach N; Temkin E; Solter E; Carmeli Y; Schwaber MJ;
    Clin Infect Dis; 2019 Mar; 68(6):964-971. PubMed ID: 29986007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):256-60. PubMed ID: 19300408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between infection control interventions and carbapenem-resistant Enterobacteriaceae incidence in an endemic hospital.
    Hussein K; Rabino G; Eluk O; Warman S; Reisner S; Geffen Y; Halif L; Paul M
    J Hosp Infect; 2017 Nov; 97(3):218-225. PubMed ID: 28743504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A national intervention to prevent the spread of carbapenem-resistant Enterobacteriaceae in Israeli post-acute care hospitals.
    Ben-David D; Masarwa S; Adler A; Mishali H; Carmeli Y; Schwaber MJ
    Infect Control Hosp Epidemiol; 2014 Jul; 35(7):802-9. PubMed ID: 24915207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of colonization of health care workers by carbapenem-resistant Enterobacteriaceae in an endemic hospital: A prospective study.
    Bitterman R; Geffen Y; Rabino G; Eluk O; Warman S; Greenblatt AS; Neuberger A; Reisner SA; Hussein K; Paul M
    Am J Infect Control; 2016 Sep; 44(9):1053-4. PubMed ID: 27125914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National Policy for Carbapenem-Resistant Enterobacteriaceae (CRE) Clearance and Discontinuation of Contact Precautions for CRE Carriers in Post-Acute Care Hospitals in Israel: Impact on Isolation-Days and New Acquisitions.
    Ben-David D; Masarwa S; Fallach N; Temkin E; Solter E; Carmeli Y; Schwaber MJ;
    Clin Infect Dis; 2021 Mar; 72(5):829-835. PubMed ID: 32034414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
    Viale P; Tumietto F; Giannella M; Bartoletti M; Tedeschi S; Ambretti S; Cristini F; Gibertoni C; Venturi S; Cavalli M; De Palma A; Puggioli MC; Mosci D; Callea E; Masina R; Moro ML; Lewis RE
    Clin Microbiol Infect; 2015 Mar; 21(3):242-7. PubMed ID: 25658534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential for Interventions in a Long-term Acute Care Hospital to Reduce Transmission of Carbapenem-Resistant Enterobacteriaceae in Affiliated Healthcare Facilities.
    Toth DJA; Khader K; Slayton RB; Kallen AJ; Gundlapalli AV; O'Hagan JJ; Fiore AE; Rubin MA; Jernigan JA; Samore MH
    Clin Infect Dis; 2017 Aug; 65(4):581-587. PubMed ID: 28472233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Model-Based Strategy to Control the Spread of Carbapenem-Resistant Enterobacteriaceae: Simulate and Implement.
    DalBen MF; Teixeira Mendes E; Moura ML; Abdel Rahman D; Peixoto D; Alves Dos Santos S; Barcelos de Figueiredo W; Vitale Mendes P; Utino Taniguchi L; Bezerra Coutinho FA; Massad E; Levin AS
    Infect Control Hosp Epidemiol; 2016 Nov; 37(11):1315-1322. PubMed ID: 27609341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.
    Lee BY; Bartsch SM; Wong KF; McKinnell JA; Slayton RB; Miller LG; Cao C; Kim DS; Kallen AJ; Jernigan JA; Huang SS
    Am J Epidemiol; 2016 Mar; 183(5):471-9. PubMed ID: 26861238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals.
    Knight GM; Dyakova E; Mookerjee S; Davies F; Brannigan ET; Otter JA; Holmes AH
    BMC Med; 2018 Aug; 16(1):141. PubMed ID: 30111322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Israeli National Policy for Carbapenem-Resistant Enterobacteriaceae Screening, Carrier Isolation and Discontinuation of Isolation.
    Solter E; Adler A; Rubinovitch B; Temkin E; Schwartz D; Ben-David D; Masarwa S; Carmeli Y; Schwaber MJ
    Infect Control Hosp Epidemiol; 2018 Jan; 39(1):85-89. PubMed ID: 29241475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.
    Friedman ND; Carmeli Y; Walton AL; Schwaber MJ
    Infect Control Hosp Epidemiol; 2017 May; 38(5):580-594. PubMed ID: 28294079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Invasive Infections Due to Carbapenem-Resistant Enterobacteriaceae among Adult Patients in U.S. Hospitals.
    Lodise T; Ye MJ; Zhao Q
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The associations between organizational culture and knowledge, attitudes, and practices in a multicenter Veterans Affairs quality improvement initiative to prevent methicillin-resistant Staphylococcus aureus.
    Sinkowitz-Cochran RL; Burkitt KH; Cuerdon T; Harrison C; Gao S; Obrosky DS; Jain R; Fine MJ; Jernigan JA
    Am J Infect Control; 2012 Mar; 40(2):138-43. PubMed ID: 21864944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a statewide network for carbapenem-resistant enterobacteriaceae prevention in a low-incidence region.
    Pfeiffer CD; Cunningham MC; Poissant T; Furuno JP; Townes JM; Leitz A; Thomas A; Buser GL; Arao RF; Beldavs ZG
    Infect Control Hosp Epidemiol; 2014 Apr; 35(4):356-61. PubMed ID: 24602939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.